**Abstract**

**Objective:** Caregiving-associated burden in schizophrenia and its assessment require cross-cultural validation to identify risk groups and family functioning. In a post-hoc analysis, data of two double-blind, phase-3 studies were pooled to assess the level of perceived burden among carers of Asian patients with schizophrenia treated with paliperidone palmitate 3-month (PP3M) or 1-month long-acting injectable (LAI).

**Methods:** Carers (family member/friend in contact with patient for ≥1hour/week) rated their burden of patient's illness on 0--5 scale using 31-item Involvement Evaluation Questionnaire (IEQ), which contains four subscales (domains): tension (9-items), worrying (6-items), supervision (6-items) and urging (8-items).

**Results**: Among 412 carers (52% parents) of Asian patients with schizophrenia, \>59% reported a burden of caregiving to patients with schizophrenia for ≥32 hours/week. Carer (n=171) burden reduced significantly (mean improvement \[SD\]: 6.8 \[18.48\], p-value\<0.001) from baseline (mean \[SD\]: 30.8 \[17.10\]) to study end (24.0 \[17.14\]), predominantly relieving the burden associated with worrying (2.6 points) and urging (2.7 points) domains. IEQ scores improved for patients without relapse (mean \[SD\] improvement: 7.8 \[18.64\]) and worsened for those with relapse (mean \[SD\] worsening: 0.9 \[15.52\]).This difference in relapse status did not reach 0.05 statistical significance level, due to small sample size in this analysis. Caregiver burden improvement was significant in patients on prior oral antipsychotics post switching to LAI with less leisure days impacted and less hours spent in caregiving (p\<0.001). No significant relationship was found between IEQ score improvement and any of the following factors: patient age, age of diagnosis, baseline long-acting injectable (LAI) use, number and duration of prior psychiatric hospitalizations (within 24 months prior to study entry).

**Conclusion:** A common pattern of burden was identified among carers of Asian patients with schizophrenia, and this post hoc analysis suggests that choosing an LAI treatment such as PP3M or PP1M reasonably reduces the psychosocial burden associated with caregiving.
